Source-backed biotech intelligence
Track clinical readouts, FDA decisions and company milestones in one focused research workspace.
| Date | Ticker | Drug | Stage | Event |
|---|---|---|---|---|
| Aug 25, 2026 | JAZZ | Ziihera® (zanidatamab-hrii) + chemoHER2-positive gastroesophageal adenocarcinoma (GEA) | PDUFA | Approval decision |
| Aug 27, 2026 | DTIL | ECUR-506Ornithine transcarbmylase deficiency | Phase 1/2 | Data readout |
| Aug 27, 2026 | GILD | Bictegravir/Lenacapavir (BIC/LEN) (Antiretroviral Combination)Human Immunodeficiency Virus | PDUFA | Approval decision |
| Aug 28, 2026 | IONS | Eplontersen (AKCEA-TTR-LRx) Diabetic cardiomyopathy, Transthyretin amyloidosis, Transthyretin Amyloid Cardiomyopathy | Phase 3 | Data readout |
| Aug 28, 2026 | CYTK | Aficamtennon-obstructive hypertropic cardiomyopathy (nHCM) | Phase 3 | Data readout |
Explore the public calendar and company pages.
Monitor the complete catalyst universe.
Research the events that move biotech
Our biotech catalyst calendar tracks upcoming clinical trial readouts, FDA decisions, PDUFA dates, advisory committee meetings and important company milestones. Public previews make key near-term events easy to discover, while Pro research tools provide the complete timeline.
Search by ticker, drug or indication, then follow the source-backed company page for pipeline context. Dates can change, so every catalyst is paired with verification details and a visible update timestamp whenever the source data provides one.